IRIS
MONFORTE, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.236
NA - Nord America 1.737
AS - Asia 1.142
SA - Sud America 335
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.701
RU - Federazione Russa 1.291
SG - Singapore 457
CN - Cina 326
BR - Brasile 280
IE - Irlanda 237
SE - Svezia 170
UA - Ucraina 140
VN - Vietnam 126
HK - Hong Kong 114
DE - Germania 110
GB - Regno Unito 86
FR - Francia 57
FI - Finlandia 53
IT - Italia 29
IN - India 27
AR - Argentina 23
CZ - Repubblica Ceca 21
CA - Canada 16
MX - Messico 15
IQ - Iraq 13
EC - Ecuador 12
PL - Polonia 12
TR - Turchia 10
BD - Bangladesh 9
CO - Colombia 8
UZ - Uzbekistan 7
BE - Belgio 6
ES - Italia 6
IR - Iran 6
MA - Marocco 6
SA - Arabia Saudita 6
TN - Tunisia 6
KG - Kirghizistan 5
PK - Pakistan 5
ZA - Sudafrica 5
ID - Indonesia 4
JP - Giappone 4
NL - Olanda 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.480
Salva come PNG Salva come JPEG
Città #
Moscow 352
Singapore 267
Jacksonville 262
Dublin 237
Ashburn 205
Dallas 185
Chandler 182
Nyköping 134
Hong Kong 114
Beijing 111
San Jose 97
Dong Ket 70
Los Angeles 50
Dearborn 42
Cambridge 41
Medford 40
Princeton 40
The Dalles 36
Lauterbourg 35
Ann Arbor 33
Des Moines 30
Buffalo 27
Boardman 24
Lancaster 24
São Paulo 22
Brno 20
Munich 18
Ho Chi Minh City 17
New York 17
Nanjing 16
Tianjin 15
Hanoi 12
San Mateo 12
Wilmington 12
Shenyang 11
Guangzhou 10
Warsaw 10
Houston 9
Jinan 9
Milan 9
Montreal 9
Redondo Beach 9
Frankfurt am Main 8
San Francisco 8
Shanghai 8
Turku 8
Edinburgh 7
Orem 7
Poplar 7
Stockholm 7
Tashkent 7
Zhengzhou 7
Ardabil 6
Belo Horizonte 6
Brooklyn 6
Chennai 6
Fuzhou 6
Hebei 6
Manchester 6
Mumbai 6
Ningbo 6
Phoenix 6
Quito 6
Atlanta 5
Baghdad 5
Bishkek 5
Brussels 5
Chicago 5
Guayaquil 5
Haikou 5
Istanbul 5
Lahore 5
Medellín 5
Nanchang 5
Rio de Janeiro 5
Augusta 4
Campinas 4
Changsha 4
Denver 4
Helsinki 4
Johannesburg 4
Ourinhos 4
Pune 4
Querétaro 4
Taizhou 4
Tunis 4
Amsterdam 3
Baku 3
Casablanca 3
Conselheiro Lafaiete 3
Curitiba 3
Dakar 3
Florianópolis 3
Haiphong 3
Hangzhou 3
Hải Dương 3
João Pessoa 3
La Paz 3
Messina 3
Monmouth Junction 3
Totale 3.161
Salva come PNG Salva come JPEG
Nome #
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 287
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 235
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 198
Anti-HIV agents: design and discovery of new potent RT inhibitors 169
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 159
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 158
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 153
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 151
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 149
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 149
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 144
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 139
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 137
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 136
Efficient 3D Database screening for novel HIV-1 IN inhibitors 134
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 131
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 130
Synthesis and structural features of new cyclofunctionalized benzimidazoles 126
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 126
Synthesis of new potential HIV-1 integrase inhibitors 122
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 122
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 120
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 117
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 117
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 116
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 111
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 110
ANTI-HIV AGENTS .1. SYNTHESIS AND INVITRO ANTI-HIV EVALUATION OF NOVEL 1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLES 108
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 108
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 105
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 102
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 97
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 93
Analysis of the covenant of mayors initiative in sicily 90
Structural features and anti-human immunodeficiency virus (HIV) activity of the isomers of 1-(2',6'-difluorophenyl)-1H,3H- thiazolo[3,4-a]benzimidazole, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor 90
Air quality data for Catania: Analysis and investigation casestudy 2012-2013 90
Air quality data for Catania: Analysis and investigation case study 2010-2011 88
SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY EVALUATION OF INDOLE- DERIVATIVES N-ACETAMIDO SUBSTITUTED 88
Synthesis and characterization of isomeric 2,3,3A,4-tetrahydro-1H-pyrrolo[1,2-A]benzimidazol-1-ones from 1,2-phenylenediamines and 3-acylpropionic acids 82
Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4- a]benzimidazoles 76
Analysis of vertical profile of particulates dispersion in function of the aerodynamic diameter at a congested road in Catania 75
SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL DELTA(2)- 1,2,4-OXADIAZOLINE DERIVATIVES 74
Synthesis and in vitro antitumor activity evaluation of 9- substituted 1,2,3,4-tetrahydrocarbazoles 68
NO2 concentration analysis in Urban area of Catania 67
STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANTITUMOR THIAZOLO[3,4- A]BENZIMIDAZOLE DERIVATIVES 67
Totale 5.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 23 38 73
2021/2022245 4 75 9 7 14 0 10 11 2 2 30 81
2022/2023734 53 51 48 51 58 88 9 53 291 2 25 5
2023/2024147 11 22 6 43 13 27 1 0 0 5 2 17
2024/2025810 19 22 16 74 33 48 6 130 198 58 71 135
2025/20262.620 107 142 201 145 237 625 327 366 382 88 0 0
Totale 5.514